Cargando…

Evaluation of lymph node status after neoadjuvant chemotherapy in breast cancer patients: comparison of diagnostic performance of ultrasound, MRI and (18)F-FDG PET/CT

OBJECTIVE: To evaluate the diagnostic performance of ultrasound, MRI and fluorine-18 fludeoxyglucose positron emission tomography ((18)F-FDG PET)/CT for the diagnosis of metastatic axillary lymph node (ALN) after neoadjuvant chemotherapy (NAC) and to find out histopathological factors affecting the...

Descripción completa

Detalles Bibliográficos
Autores principales:	You, S, Kang, D K, Jung, Y S, An, Y-S, Jeon, G S, Kim, T H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Institute of Radiology. 2015
Materias:	Full Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4651396/ https://www.ncbi.nlm.nih.gov/pubmed/26110204 http://dx.doi.org/10.1259/bjr.20150143

Ejemplares similares

Efficacy of US, MRI, and F-18 FDG-PET/CT for Detecting Axillary Lymph Node Metastasis after Neoadjuvant Chemotherapy in Breast Cancer Patients
por: Turan, Umit, et al.
Publicado: (2021)

(18)F-FDG PET–CT Diagnosis of Tuberculosis in Celiac Lymph Nodes
por: Mao, Xi Bao, et al.
Publicado: (2020)

The Efficacy of 18F-FDG PET/CT and Superparamagnetic Nanoferric Oxide MRI in the Diagnosis of Lung Cancer and the Value of 18F-FDG PET/CT in the Prediction of Lymph Node Metastasis
por: Yao, Lan, et al.
Publicado: (2021)

FDG-PET/CT lymph node staging after neoadjuvant chemotherapy in patients with adenocarcinoma of the esophageal–gastric junction
por: Fencl, Pavel, et al.
Publicado: (2016)

Spectrum of [(18)F]FDG-PET/CT Findings in Benign Lymph Node Pathology
por: Zeman, Merissa N., et al.
Publicado: (2021)

Monitoring tumor response to neoadjuvant chemotherapy using MRI and (18)F-FDG PET/CT in breast cancer subtypes
por: Schmitz, Alexander M. Th., et al.
Publicado: (2017)

Feasibility of FDG PET/CT to monitor the response of axillary lymph node metastases to neoadjuvant chemotherapy in breast cancer patients
por: Straver, Marieke E., et al.
Publicado: (2010)

Predictive Value of [(18)F]FDG PET/CT for Lymph Node Metastasis in Rectal Cancer
por: Kim, Sung Hoon, et al.
Publicado: (2019)

The Clinical Usefulness of (18)F-FDG PET/CT for the Evaluation of Lymph Node Metastasis in Periorbital Malignancies
por: Baek, Chung-Hwan, et al.
Publicado: (2009)

The role of 18F-FDG PET/CT in pediatric lymph-node acute lymphoblastic leukemia involvement
por: Cistaro, Angelina, et al.
Publicado: (2015)

Disseminated sarcoidosis involving lymph nodes, bone and spleen with progressive cardiac sarcoidosis on (18)F-FDG PET/CT and cardiac MRI
por: Yuheng Jiang, James, et al.
Publicado: (2021)

Clinical prediction model based on 18F-FDG PET/CT plus contrast-enhanced MRI for axillary lymph node macrometastasis
por: Kawaguchi, Shun, et al.
Publicado: (2022)

Combination of (18)F-FDG PET/CT and convex probe endobronchial ultrasound elastography for intrathoracic malignant and benign lymph nodes prediction
por: Zhi, Xinxin, et al.
Publicado: (2022)

Heterogeneous uptake of (18)F-FDG and (18)F-PSMA-1007 PET/CT in lung cancer and lymph node metastasis
por: Hu, Yuan, et al.
Publicado: (2023)

Evaluation of mediastinal lymph nodes using (18)F-FDG PET-CT scan and its histopathologic correlation
por: Kumar, Arvind, et al.
Publicado: (2011)

Solitary Internal Mammary Lymph Node Metastases Detected by (18)F-FDG-PET/CT in Ovarian Cancer
por: Bernardi, Alessandra, et al.
Publicado: (2011)

A Case Report: Systemic Lymph Node Tuberculosis Mimicking Lymphoma on (18)F-FDG PET/CT
por: Wang, Qingxuan, et al.
Publicado: (2016)

Initial Staging of Locally Advanced Rectal Cancer and Regional Lymph Nodes: Comparison of Diffusion-Weighted MRI With 18F-FDG-PET/CT
por: Cerny, Milena, et al.
Publicado: (2016)

Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019)

Prediction of Primary Tumour and Axillary Lymph Node Response to Neoadjuvant Chemo(Targeted) Therapy with Dedicated Breast [18F]FDG PET/MRI in Breast Cancer
por: de Mooij, Cornelis M., et al.
Publicado: (2023)

Percentage change of primary tumor on (18)F-FDG PET/CT as a prognostic factor for invasive ductal breast cancer with axillary lymph node metastasis: Comparison with MRI
por: Yoo, Jang, et al.
Publicado: (2017)

Generalized Lymph Node Activation after Influenza Vaccination on (18)F FDG-PET/CT Imaging, an Important Pitfall in PET Interpretation
por: Ayati, Narjess, et al.
Publicado: (2017)

The Comparative Study of Ultrasonography, Contrast-Enhanced MRI, and (18)F-FDG PET/CT for Detecting Axillary Lymph Node Metastasis in T1 Breast Cancer
por: Hwang, Seung Ook, et al.
Publicado: (2013)

Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer
por: Fasmer, Kristine E., et al.
Publicado: (2020)

PET-CT for Evaluation of Spleen and Liver (18)F-FDG Diffuse Uptake Without Lymph Node Enlargement in Lymphoma
por: Rao, Liangjun, et al.
Publicado: (2016)

Lymph node tuberculosis mimicking malignancy on (18)F-FDG PET/CT in two patients: A case report
por: Ding, Rui-Lin, et al.
Publicado: (2017)

(18)F-FDG PET/CT Radiomics for Preoperative Prediction of Lymph Node Metastases and Nodal Staging in Gastric Cancer
por: Liu, Qiufang, et al.
Publicado: (2021)

(18)F-FDG PET/CT-based radiomics nomogram for the preoperative prediction of lymph node metastasis in gastric cancer
por: Xue, Xiu-qing, et al.
Publicado: (2022)

Respiratory motion correction in F-18-FDG PET/CT impacts lymph node assessment in lung cancer patients
por: Noto, Benjamin, et al.
Publicado: (2022)

18F-FDG PET/MRI and 18F-FDG PET/CT for the Management of Gynecological Malignancies: A Comprehensive Review of the Literature
por: Allahqoli, Leila, et al.
Publicado: (2023)

Early Assessment of Response to Neoadjuvant Chemotherapy with (18)F-FDG-PET/CT in Patients with Advanced-Stage Ovarian Cancer
por: Chung, Young Shin, et al.
Publicado: (2020)

Predicting Response to Neoadjuvant Chemotherapy Using 18F FDG PET-CT in Patients with Locally Advanced Breast Cancer
por: Hulikal, Narendra, et al.
Publicado: (2020)

Diagnostic value of dynamic (18)F-FDG PET/CT imaging in non-small cell lung cancer and FDG hypermetabolic lymph nodes
por: Sun, Yishan, et al.
Publicado: (2023)

Transient (18)FDG-avid hilar lymph node on PET/CT imaging in asymptomatic COVID-19
por: Karimi-Galougahi, Mahboobeh, et al.
Publicado: (2020)

Evaluation of Mediastinal Lymph Nodes in Sarcoidosis, Sarcoid Reaction, and Malignant Lymph Nodes Using CT and FDG-PET/CT
por: Koo, Hyun Jung, et al.
Publicado: (2015)

The sensitivity and specificity of (18)F-FDG PET/CT in spinal leptomeningeal metastases: the synergistic effect of the (18)F-FDG PET-CT to gadolinium-enhanced MRI
por: Luo, Zhe-Huang, et al.
Publicado: (2023)

FDG-PET/CT for lymph node staging prior to radical cystectomy
por: Pihl, Vilhelm, et al.
Publicado: (2023)

Preoperative pelvic MRI and 2-[(18)F]FDG PET/CT for lymph node staging and prognostication in endometrial cancer—time to revisit current imaging guidelines?
por: Fasmer, Kristine E., et al.
Publicado: (2022)

Rectal lymph node metastasis in recurrent ovarian carcinoma: essential role of (18)F-FDG PET/CT in treatment planning
por: Kumagai, Koji, et al.
Publicado: (2013)

Implications of False Negative and False Positive Diagnosis in Lymph Node Staging of NSCLC by Means of (18)F-FDG PET/CT
por: Li, Shaolei, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8744gogg6p2t51anieotfcfvde